Suchergebnisse - (Subject:"Tocilizumab")

PubPharm (52)

31

Tocilizumab as monotherapy or combination therapy for treating active rheumatoid arthritis : a meta-analysis of efficacy and safety reported in randomized controlled trials

enthalten in: Arthritis research & therapy | 2016

von Teitsma, X. | Marijnissen, A. | Bijlsma, J. | +2

32

Identification of baseline gene expression signatures predicting therapeutic responses to three biologic agents in rheumatoid arthritis : a retrospective observational study

enthalten in: Arthritis research & therapy | 2016

von Nakamura, S. | Suzuki, K. | Iijima, H. | +8

33

EuroQol-5 dimensions utility gain according to British and Swedish preference sets in rheumatoid arthritis treated with abatacept, rituximab, tocilizumab, or tumour necrosis factor inhibitors : a prospective cohort study from southern Sweden

enthalten in: Arthritis research & therapy | 2016

von Gülfe, A. | Wallman, J. | Kristensen, L.

34

Early changes in blood-based joint tissue destruction biomarkers are predictive of response to tocilizumab in the LITHE study

enthalten in: Arthritis research & therapy | 2016

von Bay-Jensen, A. | Platt, A. | Siebuhr, A. | +3

35

Higher expression of TNFα-induced genes in the synovium of patients with early rheumatoid arthritis correlates with disease activity, and predicts absence of response to first line therapy

enthalten in: Arthritis research & therapy | 2016

von De Groof, A. | Ducreux, J. | Humby, F. | +6

36

Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor α agents, a retrospective cohort study

enthalten in: Arthritis research & therapy | 2015

von Curtis, J. | Sarsour, K. | Napalkov, P. | +2

37

Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab

enthalten in: Arthritis research & therapy | 2015

von Hirata, S. | Marotta, A. | Gui, Y. | +2

38

Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice : results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry

enthalten in: Arthritis research & therapy | 2015

von Sakai, R. | Cho, S. | Nanki, T. | +46

39

CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis

enthalten in: Arthritis research & therapy | 2015

von Mahmood, Z. | Muhammad, K. | Schmalzing, M. | +3

40

Peripheral blood CD4(+)CD25(+)CD127(low) regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis : increase in regulatory T cells correlates with clinical response

enthalten in: Arthritis research & therapy | 2015

von Kikuchi, J. | Hashizume, M. | Kaneko, Y. | +3